Q301--Notice of Intent to Sole Source NATERA Transplant Rejection Surveillance
Closed Special Notice Posted
- Solicitation number
- 36C25926Q0660
- Agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Integrated Service Network 19, Network Contracting Office (NCO) 19 issued a Notice of Intent to sole source molecular genetic reference testing to Natera, Inc., a large business, with interested parties responding by August 19, 2026 at 3:00 PM Mountain Standard Time. The sole-source determination rests on Natera's proprietary ownership of the three testing methodologies: Prospera molecular expression transplant assessment testing (225 units), Renasight molecular assessment for kidney disease (15 units), and Panorama noninvasive prenatal testing (20 units). The NAICS code is 621511 (Medical Laboratories) with a $41.5 million business size standard; the PSC is Q301 (Reference Laboratory Testing). Interested parties may respond by submitting capability statements, specifications, brochures, or other relevant documentation to Contracting Officer Lindsey Zwaagstra at Lindsey.Zwaagstra@va.gov, clearly demonstrating capability to meet the stated requirements. This notice is not a request for competitive quotes; the government reserves sole discretion to determine whether to compete the requirement and assumes no responsibility for response costs incurred by interested parties.
Notice text
In accordance with RFO 12.201-1, this Notice of Intent is to inform all parties the Department of Veterans Affairs, Network Contracting Office (NCO) 19 located at 6162 South Willow Drive Suite 300, Greenwood Village, CO 80111 intends to award a sole source procurement for the following requirement to the large business, Natera, Inc., located at 13011 McCallen Pass, Austin, Texas 78752:
ITEM #
DESCRIPTION OF SUPPLIES
QTY
UNIT OF ISSUE
0001
Molecular expression transplant assessment testing
225
EA
0002
Molecular Assessment for Kidney Disease
15
EA
0003
Molecular Genetic Prenatal Screening Test
20
EA
Natera Inc. is the sole source for the requested molecular genetic reference testing as the testing is proprietary to Natera. This acquisition will provide reference testing for Natera s Prospera molecular expression transplant assessment testing, Renasight molecular assessment for kidney disease, and Panorama Noninvasive prenatal test (NIPT) molecular genetic prenatal screening tests.
The associated North America Classification Systems (NAICS) Code is 621511 and the Business Size Standard is $41.5 Million.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement no later than 3:00 PM Mountain Standard Time, Wednesday, August 19th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to Lindsey.Zwaagstra@va.gov.
A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice.
Files
| File | Type | Posted |
|---|---|---|
| 36C25926Q0660.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity